| Literature DB >> 30569247 |
Mokhtar Mabrouk1,2, Sherin F Hammad1, Mohamed A Abdelaziz1,3, Fotouh R Mansour4,5.
Abstract
Ligand exchange method is introduced as an alternative to Job's and mole ratio methods for studying the stoichiometry of relatively weak metal complexes in solutions. The method involves adding varying amounts of a ligand (L) to an excess constant amount of a colored complex (MX) with appropriate stability and molar absorptivity. The absorbance of each solution is measured at the λmax of the initial complex, MX, and plotted against the concentration of the studied ligand, L. If the newly formed complex ML does not absorb at the λmax of the initial complex, then attenuation of the absorbance of the initial complex on adding varying quantities of the investigational ligand gives an inverse calibration line that intersects with the calibration curve of initial complex at a given point. If a line parallel to the ordinate is drawn from this point to the x-axis, the ratio of the two parts of the x-axis to the left and to the right (α/β) gives the metal to ligand molar ratio in the complex formed, ML. The new method has been applied to the study of the composition of iron (III) complexes with three bisphosphonate drugs: alendronate, etidronate, and ibandronate. The mole ratio was found to be 1:1 with the three investigated bisphosphonates and results were further confirmed by Job's and mole ratio methods. The ligand exchange method is simpler, quicker, easier to perform and more accurate than Job's and mole ratio methods for studying weak and relatively weak complexes.Entities:
Keywords: Bisphosphonates; Job’s method; Ligand exchange method; Mole ratio method; Relatively weak complexes
Year: 2018 PMID: 30569247 PMCID: PMC6768135 DOI: 10.1186/s13065-018-0512-4
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Fig. 1Illustrative plots of the ligand exchange method using MX as an initial complex (*) for studying the mole ratios of complexes: ML (●), ML2 (▲), and ML3 (■)
Fig. 2Molecular structures of studied bisphosphonate drugs. All compounds are presented in anhydrous forms
Fig. 3Absorption spectra of (I) etidronate (1 × 10−3 M), (II) FeCl3 (2 × 10−4 M), and (III) FeCl3 (2 × 10−4 M) + etidronate (4 × 10−4 M) all in 2 M perchloric in addition to (IV) the absorption Spectrum of Fe(III)-salicylate in water/methanol (50:50, pH 3.2)
Fig. 4An overlay of Fe(III)-salicylate calibration curve (×) with inverse calibration curves of a ibandronate (●), b alendronate (▲), and c etidronate (■)
Fig. 5Job plots of Fe(III) complexes with etidronate (■), alendronate (▲), and ibandronate (●) ([Fe(III)] + [bisphosphonate]) = 1 mM
Fig. 6Molar ratio method: plots of Fe(III) complex with etidronate (■), alendronate (▲) and ibandronate (●) ([bisphosphonate] = 0.5 mM)